Prot #VX13-661-103: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-661 in Combination With Ivacaftor for 12 Weeks in Subjects With Cystic Fibrosis, Homo

Project: Research project

Project Details

StatusFinished
Effective start/end date4/23/144/23/17

Funding

  • Quintiles, Inc. (Prot #VX13-661-103)
  • Vertex Pharmaceuticals Incorporated (Prot #VX13-661-103)